Work

Development of an oral prime–boost strategy to elicit broadly neutralizing antibodies against HIV-1

Year: 2002

Type: review

Source: Vaccine

DOI: 10.1016/s0264-410x(02)00080-4

Authors: Anthony L Devico, Timothy R Fouts, Mohamed T Shata, Roberta Kamin-Lewis, George K Lewis, David M Hone

Institutions: University of Maryland, Baltimore, University of Maryland Biotechnology Institute

Language: English

Topic: HIV Research and Treatment

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases

Awards: G1169356817, G1276676668, INTEGRATED AIDS VACCINE DEVELOPMENT PROGRAM, IMMUNOGENICITY OF ORAL SIV &HIV1 VACCINES, G262266631, SINGLE CHAIN HIV GP120-CD4 COMPLEX, MACROPHAGE DERIVED CHEMOKINE AND HIV INFECTION, G3684574269, G3711787925, G3810658085, HIV-1 PASSIVE IMMUNITY AGAINST CORECEPTOR INTERACTIONS, G4255095504, G4654131459, NOVEL HIV VACCINES, G8420415896, CD8+ T CELLS IN PRIMARY INFECTION

OpenAlex ID: W2061305690

FWCI: 1.001

Cites: 82

Cited by: 46

Related to: 10